Hedgehog/Gli supports androgen signaling in androgen deprived and androgen independent prostate cancer cells. - Inserm - Institut national de la santé et de la recherche médicale Access content directly
Journal Articles Molecular Cancer Year : 2010

Hedgehog/Gli supports androgen signaling in androgen deprived and androgen independent prostate cancer cells.

Mengqian Chen
  • Function : Author
  • PersonId : 909667
Michael Feuerstein
  • Function : Author
  • PersonId : 909668
Elina Levina
  • Function : Author
  • PersonId : 909669
Prateek Baghel
  • Function : Author
  • PersonId : 909670
Richard Carkner
  • Function : Author
  • PersonId : 909671
Matthew Tanner
  • Function : Author
  • PersonId : 909672
Michael Shtutman
  • Function : Author
  • PersonId : 909673
Francis Vacherot
  • Function : Author
  • PersonId : 959438
Stéphane Terry
  • Function : Author
  • PersonId : 909674
Alexandre de La Taille
  • Function : Author
  • PersonId : 851748


BACKGROUND: Castration resistant prostate cancer (CRPC) develops as a consequence of hormone therapies used to deplete androgens in advanced prostate cancer patients. CRPC cells are able to grow in a low androgen environment and this is associated with anomalous activity of their endogenous androgen receptor (AR) despite the low systemic androgen levels in the patients. Therefore, the reactivated tumor cell androgen signaling pathway is thought to provide a target for control of CRPC. Previously, we reported that Hedgehog (Hh) signaling was conditionally activated by androgen deprivation in androgen sensitive prostate cancer cells and here we studied the potential for cross-talk between Hh and androgen signaling activities in androgen deprived and androgen independent (AI) prostate cancer cells. RESULTS: Treatment of a variety of androgen-deprived or AI prostate cancer cells with the Hh inhibitor, cyclopamine, resulted in dose-dependent modulation of the expression of genes that are regulated by androgen. The effect of cyclopamine on endogenous androgen-regulated gene expression in androgen deprived and AI prostate cancer cells was consistent with the suppressive effects of cyclopamine on the expression of a reporter gene (luciferase) from two different androgen-dependent promoters. Similarly, reduction of smoothened (Smo) expression with siRNA co-suppressed expression of androgen-inducible KLK2 and KLK3 in androgen deprived cells without affecting the expression of androgen receptor (AR) mRNA or protein. Cyclopamine also prevented the outgrowth of AI cells from androgen growth-dependent parental LNCaP cells and suppressed the growth of an overt AI-LNCaP variant whereas supplemental androgen (R1881) restored growth to the AI cells in the presence of cyclopamine. Conversely, overexpression of Gli1 or Gli2 in LNCaP cells enhanced AR-specific gene expression in the absence of androgen. Overexpressed Gli1/Gli2 also enabled parental LNCaP cells to grow in androgen depleted medium. AR protein co-immunoprecipitates with Gli2 protein from transfected 293T cell lysates. CONCLUSIONS: Collectively, our results indicate that Hh/Gli signaling supports androgen signaling and AI growth in prostate cancer cells in a low androgen environment. The finding that Gli2 co-immunoprecipitates with AR protein suggests that an interaction between these proteins might be the basis for Hedgehog/Gli support of androgen signaling under this condition.
Fichier principal
Vignette du fichier
1476-4598-9-89.pdf (860.47 Ko) Télécharger le fichier
1476-4598-9-89-S1.PDF (206.95 Ko) Télécharger le fichier
1476-4598-9-89-S2.PDF (92.69 Ko) Télécharger le fichier
1476-4598-9-89.xml (108.4 Ko) Télécharger le fichier
Origin : Publisher files allowed on an open archive
Format : Other
Format : Other
Format : Other

Dates and versions

inserm-00622574 , version 1 (12-09-2011)



Mengqian Chen, Michael Feuerstein, Elina Levina, Prateek Baghel, Richard Carkner, et al.. Hedgehog/Gli supports androgen signaling in androgen deprived and androgen independent prostate cancer cells.. Molecular Cancer, 2010, 9 (1), pp.89. ⟨10.1186/1476-4598-9-89⟩. ⟨inserm-00622574⟩


270 View
356 Download



Gmail Facebook Twitter LinkedIn More